Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Modrusan, Zora

Class:IdPerson:2399672
_displayNameModrusan, Zora
_timestamp2012-07-12 16:15:45
created[InstanceEdit:2399709] Orlic-Milacic, M, 2012-07-12
firstnameZora
initialZ
surnameModrusan
(author)[LiteratureReference:2399688] Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation
[LiteratureReference:5690747] Loss of the tumor suppressor BAP1 causes myeloid transformation
[LiteratureReference:8979601] IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
[LiteratureReference:9710293] IRF2 transcriptionally induces GSDMD expression for pyroptosis
[LiteratureReference:9768685] TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer
[LiteratureReference:9768686] miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer
[Change default viewing format]
No pathways have been reviewed or authored by Modrusan, Zora (2399672)